Table 1.
Associations of tumor type with clinico-pathological features
| Endometrioid | Non-endometrioid | P value | ||
|---|---|---|---|---|
| N | 109 | 76 | 33 | |
|
| ||||
| Age | <60 years | 60 | 20 | 0.046 |
| >= 60 years | 16 | 13 | ||
|
| ||||
| Age (median, range) | 55 (25–81) | 54.5 (37–80) | 0.22 | |
|
| ||||
| Tumor size (median, range) | 11.8 (0.4–30) | 8 (3.5–18.5) | 0.02 | |
|
| ||||
| pT stage | I | 53 | 6 | <0.001 |
| IA | 24 | 5 | ||
| IB | 2 | 0 | ||
| IC | 27 | 1 | ||
| II | 14 | 3 | ||
| IIA | 4 | 0 | ||
| IIB | 3 | 0 | ||
| IIC | 7 | 3 | ||
| III | 5 | 20 | ||
| IIIA | 1 | 3 | ||
| IIIB | 0 | 0 | ||
| IIIC | 4 | 17 | ||
| IV | 1 | 4 | ||
|
| ||||
| Laterality | Unilateral | 66 | 17 | <0.001 |
| Bilateral | 10 | 16 | ||
|
| ||||
| Status at last follow-up | NED | 59 | 12 | <0.001 |
| AWD | 3 | 3 | ||
| Dead | 7 | 16 | ||
|
| ||||
| Architectural pattern | Glandular | 56 | 5 | <0.001 |
| Papillary | 12 | 6 | ||
| Solid | 7 | 17 | ||
|
| ||||
| Mitotic rate (per 10 hpf) (median, range) | 1 (1–24) | 7.5 (1–96) | <0.001 | |
|
| ||||
| FIGO grade | 1 | 54 | 0 | <0.001 |
| 2 | 18 | 8 | ||
| 3 | 4 | 25 | ||
|
| ||||
| Shimizu-Silverberg grade | 1 | 64 | 3 | <0.001 |
| 2 | 9 | 6 | ||
| 3 | 2 | 20 | ||
|
| ||||
| Squamous differentiation | Absent | 26 | 33 | <0.001 |
| Present | 50 | 0 | ||
|
| ||||
| Endometriosis | Absent | 39 | 31 | <0.001 |
| Present | 37 | 2 | ||
|
| ||||
| Adenofibroma | Absent | 60 | 33 | 0.004 |
| Present | 16 | 0 | ||
|
| ||||
| Borderline tumor | Absent | 44 | 33 | <0.001 |
| Present | 32 | 0 | ||
|
| ||||
| Number of CEFs | 0 | 15 | 31 | <0.001 |
| 1 | 16 | 2 | ||
| 2 | 24 | 0 | ||
| 3 | 13 | 0 | ||
| 4 | 8 | 0 | ||
|
| ||||
| Concurrent endometrial tumor | Absent | 46 | 29 | <0.001 |
| Present | 28 | 1 | ||
|
| ||||
| P16 | Negative | 28 | 4 | 0.003 |
| Positive | 3 | 6 | ||
|
| ||||
| P53 | Negative | 30 | 5 | <0.001 |
| Positive | 0 | 5 | ||
|
| ||||
| WT-1 | Negative | 29 | 1 | <0.001 |
| Positive | 1 | 9 | ||